Shares in Danish drugmaker Novo Nordisk were down nearly 20% in pre-market trading Tuesday morning after the company cuts its ...

U.S.-listed shares of Novo Nordisk sank in premarket trading Tuesday after the Danish drugmaker cut its full-year outlook and ...

Danish pharma giant Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to ...

The company has looked internally for its new leader, as Doustdar is currently serving as its head of international ...

Novo Nordisk A/S promoted its head of international operations to become its new chief executive officer after a profit warning due to slumping weight-loss drug sales that wiped more than $90 billion ...

Shares in Novo Nordisk plunged as much as 30% after the Danish drugmaker cut its guidance and named a new chief executive, as it pins its hopes on a company veteran to revive growth.The company said ...